Lv41
690 积分 2021-06-24 加入
FDA new drug approvals in Q1 2026
24天前
已完结
Caspase-4 dimerisation and D289 auto-processing elicit an interleukin-1β-converting enzyme
1个月前
已完结
P32 of caspase-4 C258A mutant
2个月前
已关闭
Discovery of Novel Disubstituted l-Prolinamide Derivatives as Selective PI3Kα Inhibitors for Anticancer Therapy
2个月前
已完结
Structure of the human PKD1-PKD2 complex
2个月前
已完结
Discovery of Novel Spirocyclic MAT2A Inhibitors Demonstrating High In Vivo Efficacy in MTAP-Null Xenograft Models
2个月前
已完结
Discovery and Characterization of Zelnecirnon (RPT193), a Potent and Selective CCR4 Antagonist for Allergic Disorders
3个月前
已完结
SH2 scan : Mapping SH2 Domain-Ligand Binding Selectivity for Inhibitors and Degraders
4个月前
已完结
Identification of potent and orally bioavailable GSPT1 molecular glue degraders
4个月前
已完结
2025 FDA approvals
4个月前
已完结
皖公网安备34019202002308
